ArticleInternal and emergency medicine2021

Effect of pegylated interferon alfa-2a in HBeAg-negative chronic hepatitis B during and 48 weeks after off-treatment follow-up: the limitation of pre-treatment HBsAg load for the seroclearance of HBsAg.

Shima Mimura et al.PubMed ↗Publisher ↗

No numbers read from the abstract.